MedPath

Evaluation of Post-Induction Hypotension Treatment with PRAM Method

Active, not recruiting
Conditions
Hypotension on Induction
Interventions
Registration Number
NCT06787404
Lead Sponsor
Ankara City Hospital Bilkent
Brief Summary

The goal of this observational study is to compare post-induction hypotension treatments with PRAM method in Gynecologic Oncological Cases. The goal of this observational study is to compare post-induction hypotension treatments with PRAM method in Gynecologic Oncological Cases.

Detailed Description

Post-induction hypotension is defined as hypotension that occurs within the first 20-30 minutes after general anesthesia induction or during the period between anesthesia induction and surgical incision. The global incidence rates are reported to be approximately 10.3%, with some studies indicating rates as high as 66.96%. Post-induction hypotension is associated with increased postoperative morbidity risks, such as acute kidney injury, transient tubular dysfunction, myocardial injury, and the need for postoperative intensive care. However, hypotension is a modifiable and preventable risk factor; its early detection and appropriate treatment can improve patient outcomes.

For this reason, investigators aimed to investigate the repeated dose requirements of alpha-adrenergic drugs, the recurrence of hypotension, and their effects on parameters observed via the MostCare monitor in patients undergoing major gynecologic oncologic surgeries during standard anesthesia induction and maintenance. This investigation focuses on patients experiencing a mean arterial pressure \<65 mmHg or a \>30% reduction in baseline systolic blood pressure within the first 30 minutes after induction or until surgical incision. Additionally, our secondary aim is to examine other parameters that may be associated with post-induction hypotension.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • Above 18 years old
  • Operated for Gynecologic Oncological reasons
  • BMI<35
Exclusion Criteria
  • Refusal to participate in the study
  • Additional spinal or epidural anesthesia
  • Dementia patients from whom consent could not be obtained
  • Atrial fibrillation with a rapid ventricular response
  • Patients with difficult ventilation and/or difficult intubation
  • Left ventricular ejection fraction (EF) below 30%
  • Severe aortic valve stenosis
  • Obesity (BMI >35)
  • Chronic beta-blocker use

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
EphedrineEphedrineWhen post-induction hypotension occurred patients were treated with 5 milligrams ephedrine in this group. If blood pressure does not reach desired levels, same dosage will be repeated 5 minutes later from administration. Maximum 3 doses will be applied and if hypotension ist persist the treatment will changed to rescue treatment.
NoradrenalineNoradrenalinWhen post-induction hypotension occurred patients were treated with 5 micrograms noradrenaline in this group. If blood pressure does not reach desired levels, same dosage will be repeated 5 minutes later from administration. Maximum 3 doses will be applied and if hypotension ist persist the treatment will changed to rescue treatment.
Primary Outcome Measures
NameTimeMethod
"Is there a difference in the need for repeated doses of treatments to reach the target blood pressure in patients who develop post-induction hypotension?"First 30 minutes after anesthesia induction or time to skin incision

When hypotension is occured, researchers applied two treatment (e.g. Ephedrine and Norepinephrine) and assessed how many hypotension episodes occured after treatment

"Is there a difference in the time to reach the target blood pressure after treatments in patients who develop post-induction hypotension?"First 30 minutes after anesthesia induction or time to skin incision

When hypotension is occured, researchers applied two treatment (e.g. Ephedrine and Norepinephrine) and assessed that is there a difference in the time to reach the target blood pressure after treatments

Secondary Outcome Measures
NameTimeMethod
Systemic vascular resistance (SVR)First 30 minutes after anesthesia induction or time to skin incision

To examine the effects of the applied treatments on the systemic vascular resistance from the PRAM method and compare them with each other.

Arterial Elastance (Ea)First 30 minutes after anesthesia induction or time to skin incision

To examine the effects of the applied treatments on the Ea from the PRAM method and compare them with each other.

Cardiac Output (CO)First 30 minutes after anesthesia induction or time to skin incision

To examine the effects of the applied treatments on the CO from the PRAM method and compare them with each other.

Stroke Volume (SV)First 30 minutes after anesthesia induction or time to skin incision

To examine the effects of the applied treatments on the SV from the PRAM method and compare them with each other.

Cardiac Cycle Efficiency (CCE)First 30 minutes after anesthesia induction or time to skin incision

To examine the effects of the applied treatments on the CCE from the PRAM method and compare them with each other.

Trial Locations

Locations (1)

Ankara Bilkent Şehir Hastanesi

🇹🇷

Ankara, Turkey

© Copyright 2025. All Rights Reserved by MedPath